Director, Portfolio and Pipeline Strategy - Immunology

Band

Level 6

 

Job Description Summary

The Director, Portfolio and Pipeline Strategy, Immunology will support the TA Head, GM and the ED, Portfolio & Pipeline Strategy by working cross-functionally to build the foundation for sustainable and profitable growth of the CV TA over the 10+ year horizon, in line with the enterprise operating model. Fundamental areas of the job include:

1. Partnering with the TA Head, GMs and ED, Portfolio and Pipeline Strategy role to build forward looking competitive readiness plans (strategy, tactical and scenario planning) that are rooted in understanding of the external competitive environment in close collaboration with IDS (built on CI team deliverables), and our internal product/portfolio strategies. This role ensures our product/portfolio teams are in a constant state of readiness to anticipate and act on external macro-environmental market changes, competitor new launches and other competitor strategies in a legal and compliant manner.

2. Supporting the TA Head, GMs and/or ED, Portfolio & Pipeline Strategy to provide input on assets to S&G, Development and BioMedical Research that ensures maximal commercial viability and launch value generation. This will include Life Cycle Management (LCM) planning for new indications, formulations and labels for in-line products as well as Integrated Evidence Plans and LCM Plans for early pipeline as-sets.

3. Supporting the TA Head, GMs and/or ED, Portfolio & Pipeline Strategy to help partner with US BD&L and US Market Access to provide country level input for BD&L evaluations in line with the C&BD deal archetype guidance. This will include input such as TPP development, stakeholder research, DC/IMB prep etc.

4. Support strategic evaluations and initiatives that inform the DA and TA strategies and support TA Head and the ED, Portfolio and Pipeline Strategy with input for TAL (eg. White Papers/Position Papers; what are competitive levers now & future; what are current gaps in portfolio mix; identification of emerging are-as of unmet needs, etc.)


5. Support or lead the transition of late-stage pipeline assets from S&G to US Commercial 6+ months before FDP (timing determined with TAL and IMB), contributing to the preparation of the FDP submission package, including commercial strategy, market shaping activities, representing US Commercial needs at critical forums (GPT) up to transition to a full IPST.

 

Job Description

Key Responsibilities:

• Based on cross-functional alignment of key competitors/competitor activities outlined by the CI function, perform strategic assessments of select competitor activities, including market situation analysis, inputs into brand/portfolio forecasting impact, strategic and operational benchmarking, articulation of implications and drive development of a cross-functional competitive response plan in legal and compliant manner. All in close partnership with IDS
• Monitor/benchmark strategic plans in context of developments of competitors to provide early warning for potential threats and opportunities for successful implementation of prioritized critical initiatives and tactical plans.
• Proactive surveillance of core Disease Area healthcare & macroeconomic environment including policy, regulatory, health technology to identify threats and opportunities relevant to planning initiatives in the US, and identify critical business trends in advance to drive portfolio growth in the future.
• In collaboration with the CI team, drive the design and execution of competitive planning initiatives (competitive simulations) for key products subject to significant competitive events. Ensure the effective implementation and integrity of all competitive and business intelligence activities such as primary research, and other appropriate intelligence gathering and analysis projects through timely and appropriate coordination with team members and external vendors.
• Lead strategic planning for lifecycle management (LCM) across the Therapeutic Area portfolio with focus on maximizing the long-term value of our assets
• Work closely with cross-functional teams including Medical Affairs, Global Drug Development, Strategy & Growth, Novartis Technical Operations, Regulatory, Finance, IDS, Supply Chain, Trade and Market Access to ensure realization of LCM, Competitive Readiness & Pipeline Strategy priorities. Proactively address/manage risks and issue escalation. Ensure close coordination with peers and key matrix partners, on forecasts and cost projections and appropriate coordination with team members, and external vendors
• Liaison with key cross-functional partners such as IDS, Market Access, Medical, BD&L, M&A, Biomedical Research, Development and S&G team